Increased Serum 1,25-Dihydroxyvitamin D after Growth Hormone Administration is not Parathyroid Hormone-Mediated

[1]  C. Ohlsson,et al.  Growth hormone and bone. , 1998, Endocrine reviews.

[2]  B. Hollis,et al.  Effect of growth hormone on bone: Bone mineral density, trabecular bone volume, and alkaline phosphatase improve or are restored in the dwarf rat treated with growth hormone , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  A. Pasquino,et al.  Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long-term growth hormone therapy. , 1995, European journal of endocrinology.

[4]  F. Vrtovsnik,et al.  Local action of phosphate depletion and insulin-like growth factor 1 on in vitro production of 1,25-dihydroxyvitamin D by cultured mammalian kidney cells. , 1994, The Journal of clinical investigation.

[5]  B. Moore,et al.  Changes in body composition and bone density after discontinuation of growth hormone therapy in adolescence: an interim report , 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[6]  J. Kanis.  Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism , 1994 .

[7]  D. Johnston,et al.  The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism * , 1994, Clinical endocrinology.

[8]  A. Rosenberg,et al.  Effects of growth hormone treatment for short stature on calcium homeostasis, bone mineralisation, and body composition. , 1994, Hormone research.

[9]  M. Drezner,et al.  Insulin-like growth factor-I regulation of renal 25-hydroxyvitamin D-1-hydroxylase activity. , 1993, Endocrinology.

[10]  G. Saggese,et al.  Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. , 1993, The Journal of pediatrics.

[11]  S. Lamberts,et al.  The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition , 1992, Clinical endocrinology.

[12]  L. Tatò,et al.  Effects of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiency. , 1991, The Journal of pediatrics.

[13]  R. Marcus,et al.  Effects of short term administration of recombinant human growth hormone to elderly people. , 1990, The Journal of clinical endocrinology and metabolism.

[14]  R. Tsang,et al.  Effects of growth hormone replacement therapy on 1,25-dihydroxyvitamin D and calcium metabolism. , 1983, The Journal of clinical endocrinology and metabolism.

[15]  A. Norman,et al.  Calcium and vitamin D metabolism in acromegaly. , 1981, Acta endocrinologica.

[16]  E. Canalis,et al.  Effect of insulinlike growth factor I on DNA and protein synthesis in cultured rat calvaria. , 1980, The Journal of clinical investigation.

[17]  J. Zerwekh,et al.  Effect of Growth Hormone Administration: Reciprocal Changes in Serum lα,25-Dihydroxyvitamin D and Intestinal Calcium Absorption* , 1980 .

[18]  A. Norman,et al.  Effects of vitamin D metabolites on bovine parathyroid hormone release in vitro. , 1980, The American journal of physiology.

[19]  H. Rasmussen,et al.  Parathyroid function and vitamin D metabolism during human growth hormone replacement. , 1979, The Journal of clinical endocrinology and metabolism.

[20]  M. Dietel,et al.  Influence of vitamin D3, 1,25-dihydroxyvitamin D3, and 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion, adenosine 3',5'-monophosphate release, and ultrastructure of parathyroid glands in organ culture. , 1979, Endocrinology.

[21]  H. DeLuca,et al.  Vitamin D. Metabolism and mechanism of action. , 1973, World review of nutrition and dietetics.

[22]  J. Daly,et al.  Direct method for determining inorganic phosphate in serum with the "CentrifiChem". , 1972, Clinical chemistry.

[23]  R. Richterich.  Clinical chemistry : theory and practice , 1969 .